Tag: Montelukast COVID trial

Asthma drug found to block coronavirus from replicating: IISc Bengaluru study

Drugs used to treat asthma and allergies can bind and block important proteins produced by the SARS-COV-2 virus, and reduce virus replication in human immune cells, according to a new study by researchers at the Indian Science Institute (IISC).Approved by the US Food and Drug Administration (FDA), drugs, called Montelukast, has been there for more…

continue reading